World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
73
Citations
26843
World Ranking
2093
National Ranking
1021

Research.com Recognitions

  • 2007 - Fellow of John Simon Guggenheim Memorial Foundation

Overview

Nancy J. Sullivan is affiliated with the National Institutes of Health in the United States. Their research primarily spans the field of Medicine, with significant contributions to Infectious Diseases, Molecular Biology, and Epidemiology. Additional subfields include Animal Science and Zoology as well as Immunology.

Their main research topics focus on SARS-CoV-2 and COVID-19, with extensive work in Viral Infections and Outbreaks Research, COVID-19 Clinical Research Studies, and viral infections involving vectors and animals. Immunotherapy and immune response mechanisms also feature prominently in their portfolio.

Frequent publication venues for this researcher include bioRxiv (Cold Spring Harbor Laboratory), Science, Science Translational Medicine, New England Journal of Medicine, and Cell Reports.

  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates, 2020, New England Journal of Medicine
  • SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters, 2022, Nature
  • Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine, 2021, New England Journal of Medicine
  • LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants, 2022, Cell Reports
  • Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates, 2021, Science

The scientist has collaborated frequently with John R. Mascola, Lingshu Wang, Juan I. Moliva, Barney S. Graham, and Peter D. Kwong, indicating sustained coauthorship in multiple projects.

Nancy J. Sullivan has been recognized as a Fellow of the John Simon Guggenheim Memorial Foundation, an award received in 2007.

Best Publications

  • The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates

    Hyeryun Choe;Michael Farzan;Ying Sun;Nancy Sullivan

  • Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.

    A Trkola;M Purtscher;T Muster;C Ballaun

  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.

    Kizzmekia S Corbett;Barbara Flynn;Kathryn E Foulds;Joseph R Francica

  • SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

    Unknown

  • Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection

    Kartik Chandran;Nancy J. Sullivan;Ute Felbor;Sean P. Whelan

  • CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro

    Lijun Wu;William A. Paxton;Nasim Kassam;Nancy Ruffing

  • Development of a preventive vaccine for Ebola virus infection in primates

    Nancy J. Sullivan;Anthony Sanchez;Pierre E. Rollin;Zhi Yong Yang

  • Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

    Steven M. Jones;Heinz Feldmann;Heinz Feldmann;Ute Ströher;Ute Ströher;Joan B. Geisbert

  • LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

    Unknown

  • Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

    Nancy J. Sullivan;Thomas W. Geisbert;Joan B. Geisbert;Ling Xu

  • Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

    Zhi Yong Yang;Henricus J. Duckers;Nancy J. Sullivan;Anthony Sanchez

  • A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report

    Jason A. Regules;John H. Beigel;Kristopher M. Paolino;Jocelyn Voell

  • Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.

    N. Sullivan;Ying Sun;J. Li;W. Hofmann

  • Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

    Davide Corti;John Misasi;Sabue Mulangu;Daphne A. Stanley

  • Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.

    Kai Wu;Anne P Werner;Matthew Koch;Angela Choi

  • Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

    Daphne A Stanley;Anna N Honko;Anna N Honko;Clement Asiedu;John C Trefry

  • Two Orphan Seven-Transmembrane Segment Receptors Which Are Expressed in CD4-positive Cells Support Simian Immunodeficiency Virus Infection

    Michael Farzan;Hyeryun Choe;Kathleen Martin;Luisa Marcon

  • Chimpanzee Adenovirus Vector Ebola Vaccine

    Julie E. Ledgerwood;Adam D. DeZure;Daphne A. Stanley;Emily E. Coates

  • mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

    Unknown

  • A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

    Katie Ewer;Tommy Rampling;Navin Venkatraman;Georgina Bowyer

  • Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys

    Wendelien B Oswald;Thomas W Geisbert;Kelly J Davis;Joan B Geisbert

  • A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial

    Julie E Martin;Nancy J Sullivan;Mary E Enama;Ingelise J Gordon

  • Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule.

    Nancy J. Sullivan;Julie E. Martin;Barney S. Graham;Gary J. Nabel

  • Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs.

    Nancy J Sullivan;Thomas W Geisbert;Joan B Geisbert;Devon J Shedlock

Frequent Co-Authors

Barney S. Graham
Barney S. Graham Morehouse School of Medicine
Mario Roederer
Mario Roederer National Institute of Allergy and Infectious Diseases
Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
Richard A. Koup
Richard A. Koup National Institute of Allergy and Infectious Diseases
John R. Mascola
John R. Mascola ModeX Therapeutics
Lisa E. Hensley
Lisa E. Hensley National Institutes of Health
Julie E. Ledgerwood
Julie E. Ledgerwood National Institute of Allergy and Infectious Diseases
Robert T. Bailer
Robert T. Bailer National Institute of Allergy and Infectious Diseases
Thomas W. Geisbert
Thomas W. Geisbert The University of Texas Medical Branch at Galveston
Alfredo Nicosia
Alfredo Nicosia University of Naples Federico II

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related online degrees can open diverse career opportunities in healthcare. Programs like the cheapest online pmhnp programs offer affordable pathways into specialized nursing roles that complement immunology knowledge.

Nurse practitioners with advanced degrees often enjoy competitive salaries. Understanding how much do dnps make can help prospective students evaluate the return on investment for their education and career planning.

Many clinicians start as family nurse practitioners and then specialize. Learning about the transition process, such as the steps involved in fnp to acnp, is vital for those aiming to focus on acute care settings where immunology-related expertise is crucial.

For accelerated entry, accelerated np programs provide a fast-track option to advanced practice roles, catering to students with prior healthcare experience seeking to advance efficiently.

Best Scientists Citing Nancy J. Sullivan

Trending Scientists

Recently Published Articles